BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34311608)

  • 1. Association study of
    Paul P; Nadella RK; Sen S; Ithal D; Mahadevan J; Reddy Y C J; Jain S; Purushottam M; Viswanath B
    J Psychopharmacol; 2021 Dec; 35(12):1510-1516. PubMed ID: 34311608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder.
    Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Kunugi H; Koyama T
    Psychiatr Genet; 2006 Apr; 16(2):49-50. PubMed ID: 16538178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.
    González-Castro TB; Nicolini H; Lanzagorta N; López-Narváez L; Genis A; Pool García S; Tovilla-Zárate CA
    Bipolar Disord; 2015 Feb; 17(1):27-38. PubMed ID: 25041243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P
    J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.
    Wang Z; Li Z; Chen J; Huang J; Yuan C; Hong W; Yu S; Fang Y
    Genes Brain Behav; 2012 Jul; 11(5):524-8. PubMed ID: 22548711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
    Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Szczepankiewicz A; Hauser J
    Pharmacogenomics; 2008 Nov; 9(11):1595-603. PubMed ID: 19018715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course.
    Miller S; Hallmayer J; Wang PW; Hill SJ; Johnson SL; Ketter TA
    J Psychiatr Res; 2013 Feb; 47(2):252-8. PubMed ID: 23182421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.
    Cao B; Bauer IE; Sharma AN; Mwangi B; Frazier T; Lavagnino L; Zunta-Soares GB; Walss-Bass C; Glahn DC; Kapczinski F; Nielsen DA; Soares JC
    J Affect Disord; 2016 Jul; 198():198-205. PubMed ID: 27018938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium response in bipolar disorder: No difference in GADL1 gene expression between cell lines from excellent-responders and non-responders.
    Moreira J; Courtin C; Geoffroy PA; Curis E; Bellivier F; Marie-Claire C
    Psychiatry Res; 2017 May; 251():217-220. PubMed ID: 28214779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes.
    Rybakowski JK; Suwalska A; Skibinska M; Dmitrzak-Weglarz M; Leszczynska-Rodziewicz A; Hauser J
    Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):820-3. PubMed ID: 17373693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical factors associated with lithium treatment response in bipolar disorder patients from India.
    Kapur V; Nadella RK; Sathur Raghuraman B; Saraf G; Mishra S; Srinivasmurthy N; Jain S; Del Zompo M; Viswanath B
    Asian J Psychiatr; 2019 Jan; 39():165-168. PubMed ID: 29636228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of Brain Derived Neurotrophic Factor (BDNF) Val66Met CpG site is associated with early onset bipolar disorder.
    Nassan M; Veldic M; Winham S; Frye MA; Larrabee B; Colby C; Biernacka J; Bellia F; Pucci M; Terenius L; Vukojevic V; D'Addario C
    J Affect Disord; 2020 Apr; 267():96-102. PubMed ID: 32063579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural variation in the glycogen synthase kinase 3β and brain-derived neurotrophic factor genes in Japanese patients with bipolar disorders.
    Suga Y; Yoshimoto K; Numata S; Shimodera S; Takamura S; Kamimura N; Sawada K; Kazui H; Ohmori T; Morinobu S
    Neuropsychopharmacol Rep; 2020 Mar; 40(1):46-51. PubMed ID: 31769621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
    Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF rs6265 differentially influences neurometabolites in the anterior cingulate of healthy and bipolar disorder subjects.
    Scotti-Muzzi E; Chile T; Vallada H; Otaduy MCG; Soeiro-de-Souza MG
    Brain Imaging Behav; 2023 Jun; 17(3):282-293. PubMed ID: 36630045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.
    Michelon L; Meira-Lima I; Cordeiro Q; Miguita K; Breen G; Collier D; Vallada H
    Neurosci Lett; 2006 Aug; 403(3):288-93. PubMed ID: 16787706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder.
    Zeni CP; Tramontina S; Aguiar BW; Salatino-Oliveira A; Pheula GF; Sharma A; Stertz L; Moreira Maia CR; Hutz M; Kapczinski FP; Rohde LA
    Acta Psychiatr Scand; 2016 Sep; 134(3):268-74. PubMed ID: 27209073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
    Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
    J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of BDNF Val66Met allele-specific mRNA levels in bipolar disorder.
    De Luca V; Strauss J; Semeralul M; Huang S; Li PP; Warsh JJ; Kennedy JL; Wong AH
    Neurosci Lett; 2008 Aug; 441(2):229-32. PubMed ID: 18606495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.